Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies
about
Human VRK2 (vaccinia-related kinase 2) modulates tumor cell invasion by hyperactivation of NFAT1 and expression of cyclooxygenase-2Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) studyPrimary and Secondary Chemoprevention of Malignant Melanoma.Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis.The influence of Cox-2 and bioactive lipids on hematological cancers.Aspirin and other NSAIDs as chemoprevention agents in melanomaIntestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis.Bacterial immunotherapy of gastrointestinal tumors.Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis.A molecular signature for the prediction of recurrence in colorectal cancer.Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study.Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer.Association of nonsteroidal anti-inflammatory drugs and aspirin use and the risk of head and neck cancers: a meta-analysis of observational studiesNon-steroid anti-inflammatory drugs, prostaglandins, and cancer.Use of non-steroidal anti-inflammatory drugs and risk of non-Hodgkin lymphoma: a systematic review and meta-analysis.The identification of incident cancers in UK primary care databases: a systematic review.Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study.
P2860
Q24302043-35DF00B0-CF4B-4D70-B86D-5A89884EBA00Q28597617-F1685425-3151-4C18-9B36-035E91992EFDQ30245112-AFECB4BF-9DEA-4D02-B8D9-D588DDB86CE7Q33614082-0C729A8F-610C-47FD-BBF0-B73610E5C118Q33688673-91C99683-3FF3-4D05-8C1E-8633A3068FC1Q33725012-4E0C9557-D654-47CD-AB5D-959EE18B98EEQ34104601-DB50B668-ECAB-4761-9FCD-EA8F6D43A831Q34242204-EB016C69-EFAC-4FB0-8977-EABCDC3DAFB6Q34283636-625E51C5-8B32-4CB7-A4E4-2BD9452A93BAQ34458235-3077ABD3-60CD-4517-AC47-39EBB4D250D0Q35060617-165CC59A-D5D8-45A1-A96D-A39DD5A2DAE4Q35204017-F3984704-32CB-4BA9-B412-D10D2E3C5922Q35678081-42734B72-68A5-4CE3-97E3-29A194DDB66BQ36105980-02406CFF-530B-4D8F-BAE8-B741BA653597Q36689177-AF463C7A-5BA0-4B4B-ACB4-4053F56A32A3Q38262832-23E4B334-AD6B-4678-AB2A-0C5E364205CDQ38271058-6ABC498F-4159-4F2C-8636-F59E9CFB8355Q42373340-6E00461A-165A-4129-9367-1600426690CA
P2860
Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies
@ast
Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies
@en
type
label
Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies
@ast
Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies
@en
prefLabel
Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies
@ast
Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies
@en
P2860
P356
P1476
Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies
@en
P2093
C Coupland
Y Vinogradova
P2860
P2888
P304
P356
10.1038/BJC.2011.252
P407
P577
2011-07-12T00:00:00Z
P5875
P6179
1031900787